Web Results

Acerus Pharmaceuticals Corporation - Home

www.aceruspharma.com/

Home · About Us · Our Company · Our Vision & Values · Leadership Team · Board of Directors · Technology · Products & Pipeline · ESTRACE® · NATESTO™  ...

Trimel BioPharma | LinkedIn

www.linkedin.com/company/trimel-biopharma

Trimel BioPharma Incorporated is now Trimel Pharmaceuticals Corporation. Trimel is a specialty pharmaceutical company actively developing medications for ...

Trimel Announces Closing of Exclusive Agreement for NATESTO(TM)

www.marketwired.com/press-release/trimel-announces-closing-of-exclusive-agreement-for-natesto-tsx-trl-1975138.htm

Dec 9, 2014 ... 9, 2014) - Trimel Pharmaceuticals Corporation (TSX:TRL) today ... agreement between its subsidiary, Trimel BioPharma SRL, and an affiliate of ...

Trivair Device: Home

www.trivairdevice.com/

Dose is delivered. The turbulent flow has completely emptied the device. Privacy Statement|; Terms of Use. © 2017 by Acerus Pharmaceuticals SRL.

Trimel Announces Exclusive License Agreement With Endo for ...

www.marketwired.com/press-release/trimel-announces-exclusive-license-agreement-with-endo-for-natesto-tsx-trl-1970983.htm

Nov 24, 2014 ... 24, 2014) - Trimel Pharmaceuticals Corporation (TSX:TRL) today ... Trimel Biopharma SRL, providing an affiliate of Endo International plc ...

Endo International unveils Natesto testosterone nasal gel | Mantality

mantalityhealth.com/endo-international-unveils-natesto-testosterone-nasal-gel/

Apr 23, 2015 ... Trimel BioPharma SRL announced the sale of acquisition rights to NATESTO<sup>TM</sup> testosterone nasal spray to Endo International plc in ...

Mattern Pharmaceuticals / The Nasal Company / News

mattern-pharma.com/news.php

The exclusive license rights MetP Pharma AG granted to Acerus associated with " Testosterone for women" have become in certain regions of the world ...

Endo Acquires Rights to Natesto™ Testosterone Nasal Gel

www.prnewswire.com/news-releases/endo-acquires-rights-to-natesto-testosterone-nasal-gel-300000129.html

Nov 24, 2014 ... ... diagnosed with hypogonadism, from Trimel BioPharma SRL, a wholly-owned subsidiary of Trimel Pharmaceuticals Corporation (TSX: TRL).

NCT01446042 - ClinicalTrials.gov

clinicaltrials.gov/ct2/show/NCT01446042

Sep 30, 2011 ... Further study details as provided by Trimel Biopharma SRL: Primary Outcome Measures: Serum testosterone Cavg [ Time Frame: 90 days ] ...

Natesto - FDA

www.accessdata.fda.gov/drugsatfda_docs/label/2014/205488s000lbl.pdf

To report SUSPECTED ADVERSE REACTIONS, contact Trimel. BioPharma SRL at 1-844-Natesto (1-844-628-3786) or FDA at 1-800. FDA-1088 or ...